Yanfeng Wang

15.0k total citations · 3 hit papers
294 papers, 10.6k citations indexed

About

Yanfeng Wang is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Yanfeng Wang has authored 294 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 55 papers in Surgery and 33 papers in Epidemiology. Recurrent topics in Yanfeng Wang's work include Organ Transplantation Techniques and Outcomes (41 papers), Liver Disease and Transplantation (26 papers) and Chronic Myeloid Leukemia Treatments (19 papers). Yanfeng Wang is often cited by papers focused on Organ Transplantation Techniques and Outcomes (41 papers), Liver Disease and Transplantation (26 papers) and Chronic Myeloid Leukemia Treatments (19 papers). Yanfeng Wang collaborates with scholars based in China, United States and Switzerland. Yanfeng Wang's co-authors include Qifa Ye, Margaret Dykes‐Hoberg, Yoshikatsu Kanai, Lynn A. Bristol, Jeffrey D. Rothstein, Carlos A. Pardo, Matthias A. Hediger, Ralph W. Kuncl, Devin Welty and Jin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Yanfeng Wang

280 papers receiving 10.5k citations

Hit Papers

Knockout of Glutamate Transporters Reveals a Major Role f... 1996 2026 2006 2016 1996 2004 2008 500 1000 1.5k 2.0k

Peers

Yanfeng Wang
Comparison fields: 5 of 166
  • Molecular Biology 3.4k
  • Hematology 1.9k
  • Cellular and Molecular Neuroscience 1.8k
  • Genetics 1.3k
  • Biomaterials 1.1k
Replace Marek W. Radomski with:
Marek W. Radomski Canada
Babette B. Weksler United States
Eric Jaffe United States
Marina Ziche Italy
Richard D. Minshall United States
Hang Yin China
Kenneth K. Wu United States
Anthony Rosenzweig United States
Min Wang China
Karin Scharffetter‐­Kochanek Germany
Marek W. Radomski Canada View profile →
Citations per field, relative to Yanfeng Wang
Yanfeng Wang · 1×
Citations per year, relative to Yanfeng Wang
Yanfeng Wang · 1×

Countries citing papers authored by Yanfeng Wang

Since Specialization
Citations

This map shows the geographic impact of Yanfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfeng Wang more than expected).

Fields of papers citing papers by Yanfeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfeng Wang. The network helps show where Yanfeng Wang may publish in the future.

Co-authorship network of co-authors of Yanfeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfeng Wang. A scholar is included among the top collaborators of Yanfeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfeng Wang. Yanfeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 13
4 2
5 36
6 1
7 76
8 87
9 13
10 16
11 26
12 1
13
Application of vacuum sealing drainage in abdominal surgery
0
14 1
15 2
16 2
17
Acquirement of the transgenic maize harboring Bt cry1Ah gene and analysis of its inheritable stability.
3
18
Comparison of steady-state imatinib (IM) trough levels, clinical response, and safety between Caucasian and Asian patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with 400mg and 800mg daily doses of IM in the tyrosine kinase inhibi
3
19
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study breakdown →
491
20 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026